Purpose: Conventional T 2 -weighted MRI produces a hypointense signal from iron-labeled cells, which renders quantification unfeasible. We tested a SWeep Imaging with Fourier Transformation (SWIFT) MRI pulse sequence to generate a quantifiable hyperintense signal from iron-labeled cells. Methods: Mesenchymal stem cells (MSCs) were labeled with different concentrations of iron oxide particles and examined for cell viability, proliferation, and differentiation. The SWIFT sequence was optimized to detect and quantify the amount of iron in the muscle tissue after injection of iron oxide solution and iron-labeled MSCs. Results: The incubation of MSCs with iron oxide and low concentration of poly-L-lysine mixture resulted in an internalization of up to 22 pg of iron per cell with no adverse effect on MSCs. Phantom experiments showed a dependence of SWIFT signal intensity on the excitation flip angle. The hyperintense signal from iron-labeled cells or solutions was detected, and an amount of the iron oxide in the tissue was quantified with the variable flip angle method. Conclusions: The SWIFT sequence can produce a quantifiable hyperintense MRI signal from iron-labeled cells. The graft of 18 x 10 6 cells was detectable for 19 days after injection and the amount of iron was quantifiable. The proposed protocol simplifies the detection and provides a means to quantify cell numbers. Magn Reson
INTRODUCTION
The ability of mesenchymal stem cells (MSCs) to differentiate into osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells), and adipocytes (fat cells) makes them very attractive for the treatment of bone disorders (1) . Therapeutic effects were observed in preclinical studies in which MSC treatment was used for bone fractures (2) , osteoarthritis (3) , and osteoporosis (4) . Although the translation of MSC therapy for bone disorders into the clinic is promising (5) , human studies of MSC treatment of bone diseases will require a reliable and noninvasive technique to monitor cells after transplantation.
Of the many methods used to image grafted cells, MRI has shown the most promising results (6) . Its success is the result of high spatial resolution, superior soft-tissue contrast, and availability of efficient contrast agents, the most promising of which are iron oxide nanoparticles (6) . Labeling cells with these particles provides very high sensitivity, and single cell detection has been reported (7) . Iron oxide-labeled cells were used in the first trial of in vivo detection of grafted stem cells in human (8) (9) (10) (11) . However, the hypointense (negative) signal produced by iron-labeled cells is challenging to detect and quantify in the areas of MR images with low signal intensity, such as bone. The determination of the amount of grafted cells in the target tissue is critically important for the prediction of therapeutic effect, and several techniques were developed to transform hypointense signal intensity from iron-labeled cells into a hyperintense signal using off-resonance radiofrequency (RF) excitation of water (12, 13) , echo shifts in k-space (14) , or additional refocusing gradients (15) . These MRI techniques have potential, but need further development, especially in quantification procedures.
Several methods have been developed to detect MR signals from fast relaxing spins, which can also be used to generate hyperintense signal intensity from iron-labeled cells such as ultrashort echo time (UTE) (16) (17) (18) (19) , zero echo Time (ZTE) (20) (21) (22) (23) , ZTE combined with single point imaging (SPI) (24) , and SWeep Imaging with Fourier Transformation (SWIFT) (25) . The ZTE-based methods require very short RF pulses and often use low flip angles that result in a relatively low signal-to-noise ratio (23, 26) . Because of T 2 decay of signal during the gradient ramp time, the UTE sequence cannot be used effectively for imaging objects with extremely short T 2 (T 2 < 200 ms) (27) . The SWIFT pulse sequence was introduced to image tissues with very short T 2 relaxation time. This pulse sequence uses swept RF excitation and virtually simultaneous signal acquisition in a time-shared mode in the presence of imaging gradients. This approach allows the detection of NMR signal from spins with ultrashort T 2 , reduced demand on the field gradient efficiency, and low peak amplitude of RF pulses ((25) , (28) (29) (30) (31) ). The SWIFT method has been implemented successfully for imaging dental tissue (28, 32) , lung parenchyma (33), brain calcifications (34) , and mandibular invasion by carcinoma ( (29) . Two methods for the quantification of SWIFT NMR signals from fast relaxing spins, such as iron oxide solutions, were published recently (35, 36) . One study used SWIFT to detect iron oxide-labeled stem cells that were injected into the myocardium of rats (37) .
The goals of the present study were to evaluate the feasibility of using SWIFT MRI to produce a hyperintense signal from iron-labeled MSCs in vivo, and to quantify the amount of iron in the injected area. To accomplish these goals, we conducted in vitro experiments to identify a range of iron oxide particle concentrations that would not reduce the viability of the MSCs and would produce a sharp hyperintense MRI signal from labeled cells. After that, we acquired in vivo images of grafted MSCs in the muscle tissue of mice and quantified the amount of iron in the injection site over time.
METHODS

Cells
Mouse MSCs for this study were obtained from the Dr. N. E. Lane laboratory (Center for Musculoskeletal Health, the University of California at Davis School of Medicine, Sacramento, CA, USA). Cells were maintained on uncoated T-75 plastic flasks and split at a ratio of 1:10, once a week, by gentle trypsinization and 700 rpm centrifugation for 2 min. Minimum essential medium a (MEM a) with 10% fetal bovine serum (FBS) and 1% antibioticantimycotic (PSA) supplements were used as growth media.
Labeling of Cells with Iron Oxide Particles
Iron oxide particles that have been approved by the FDA for human use were used in this study (Feraheme, Amag, Waltham, MA, USA). To label the MSCs, the iron oxide particles were mixed with the growth media at the following concentrations: 12, 25, 50, 100, 200, 400, 500, 800, and 1000 mg/mL and added into flasks with adherent cells, incubated overnight, and washed three times with phosphate buffered saline (PBS). Labeled cells were harvested by gentle trypsinization and centrifugation and kept on ice until future experiments. To improve intracellular uptake of the iron oxide particles, Feraheme was mixed with poly-L-lysine (PLL) (Sigma-Aldrich Corp, St. Louis, MO, USA). We tested both low and high concentrations of the transfection agent PLL in our experiments. For the low transfection agent mixture, we added 375 ng of PLL for each 50 mg of Feraheme and stirred the mixture at room temperature for 60 min (38) (39) (40) . For the high transfection agent mixture, we added 3750 ng of PLL for every 50 mg of Feraheme and stirred the mixture at room temperature for 60 min. The Fe-PLL mixtures were then added to MSCs and incubated overnight. After incubation, the labeled cells were washed with PBS, harvested, and kept on ice until needed. Intracellular concentrations of iron in MSCs were measured by the inductively coupled mass spectroscopy method at the University of California, Davis, chemistry core facility (41) .
Viability of Iron-Labeled MSCs
A higher concentration of iron oxide particles has been shown to be better for detecting grafted cells with T 2 -weighted imaging (42) ; however, an excess of the contrast agent can be toxic for the donor cells. To determine nontoxic concentrations of the iron oxide for MSCs that are sufficient for generating a hyperintense signal, we incubated MSCs with several concentrations of Feraheme and Feraheme-PLL mixtures. We performed a colorimetric assay to measure the metabolic activity of mitochondria to determine if there was a toxic effect from the iron oxide particles. The MSCs were seeded into a 96-well flat-bottom plate at approximately 60% confluency and cultured for 3 to 4 h with 100 ml of growth media per well. After the cells' attachment, the Feraheme or Feraheme-PLL mixtures were added with final concentrations of 12, 25, 50, 100, 200, 400, 500, 800, and 1000 mg/mL of iron oxide, and cells were incubated overnight at 37 C and 5% of CO 2 . The following day, cells were washed three times with PBS to remove free iron oxide, and the cell viability assay was performed according to the manufacturer's protocol ("Cell Proliferation Reagent WST-1," Sigma-Aldrich). Briefly: 10 ml of WST-1 reagent was added per well and incubated for 4 h at 37 C and 5% of CO 2 . As a negative control, three wells with unlabeled MSCs were treated for 3 h with 400 mM of temozolomide, which is cytotoxic at higher concentrations. The cell proliferation reagent containing a tetrazolium salt WST-1 was used for the measurement of cell viability in cytotoxicity studies. The tetrazolium salt was cleaved to formazan by cellular enzymes, and the expansion in the number of viable cells resulted in an increase in the overall activity of mitochondrial dehydrogenases in the sample. This change in enzyme activity led to an increase in the amount of formazan dye formed, which directly correlated with the number of metabolically active cells in the culture. Quantification of the formazan dye produced by metabolically active cells was performed optically using an ELISA reader at 440 nm after vigorous shaking of the plate for 1 min. To determine the long-term effect of the iron oxide particles on MSCs, viability tests were also conducted at 1, 5, 10, and 21 days after iron labeling.
Differentiation of Iron-Labeled MSC
To measure the effect of iron oxide particles on osteoblast differentiation, MSCs were incubated overnight with 0, 50, 100, 200, and 400 mg/mL Feraheme and low concentration of PLL (375 ng of PLL for each 50 mg of Feraheme). After washing with PBS, the MSCs were seeded at 60% confluence in 24 well plates. Twelve hours later, regular growth media was replaced with the differentiation medium and cells were allowed to proliferate/differentiate. The differentiation media contained a-MEM, 10% FBS, 1% PSA, 50 mg/mL VitC, and 10 mM glycerol phosphate. The differentiation media was changed every 3 days. After 21 days of the proliferation/ differentiation, Alizarin Red staining (Alizarin Red S Staining Quantification Assay, ScienCell Research Laboratories, Carlsbad, CA, USA) was performed to detect osteoblasts in the culture as described previously (43) .
The number of MSCs that had differentiated into osteoblasts (alizarin positive) was determined optically at wavelength l ¼ 405 nm.
Phantom Preparation
To evaluate the ability of the SWIFT sequence to generate hyperintense MRI signal, a phantom with several concentrations of the iron oxide particles was prepared. The stock solution (30 mg/mL) was diluted several times with PBS to produce 0, 25, 50, 100, 200, 300, 600, 1200, and 30000 mg/mL solutions and was transferred into 200-mL mini-Eppendorf tubes. The tubes were placed into a custom-made holder and positioned in the RF coil.
Cell Pellet Phantom Preparation
To evaluate the relationship between R 1 relaxivity and the iron oxide concentration inside the MSCs, phantoms with a different number of cells were prepared. The 1 Â 10 6 , 2 Â 10 6 , and 3 Â 10 6 cells were incubated with 50 mg/mL of iron oxide and 375 ng/mL of PLL overnight. The following day, the cells were trypsinized, washed with PBS three times, and transferred to 200-mL Eppendorf tubes. Tubes were centrifuged at 1200 rpm, the cell pellets were imaged, and R 1 maps were reconstructed. The R 1 value of the pellet with 3 million unlabeled cells was also measured.
In Vivo Imaging of Mice after Injection of the Iron Oxide Solution
All procedures were conducted in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee of the University of California at San Francisco. To demonstrate that positive contrast can be generated using the SWIFT imaging protocol in vivo, 50 mL of 50-mg/mL Feraheme solution was injected with a 28-gauge needle intramuscularly in the hindlimb of adult female BALB/c mice (n ¼ 3, 25-35 g). Mice were anesthetized with a mixture of 2% isoflurane and pure oxygen that was delivered to the animal at a rate of 0.6 L per hour, and in vivo imaging experiments were performed approximately 1 h after injection.
In Vivo Implantation of MSCs
The 18 Â 10 6 MSCs labeled with 200 mg/mL of iron oxide were resuspended in 100 mL of PBS and injected intramuscularly in the hindlimb of adult female BALB/c mice (n ¼ 3). In vivo MR imaging was performed approximately 1 h after injection and at 3, 10, and 19 days after injection of iron-labeled cells. The primary goal of this study was to test the capability of the SWIFT sequence to produce a quantifiable hyperintense signal from ironlabeled MSCs. We injected the large number of MSCs to minimize difficulties associated with sensitivity of the method.
MR Imaging
All imaging experiments were performed with a horizontal bore 7 Tesla (T) magnet interfaced with Agilent console (Agilent/Varian, Santa Clara, CA, USA). Images of the phantom were acquired with a 38-mm ID Agilent quad birdcage coil. In vivo imaging of mouse hindlimbs were performed with a 2-cm surface coil. Positions of the phantom or animals were determined with a gradient-echo pulse sequence using the following parameters: repetition time (TR) ¼ 10 ms, echo time (TE) ¼ 4 ms, excitation flip angle ¼ 15
, field of view (FOV) ¼ 4 or 3 cm, matrix dimension ¼ 128 Â 128, slice thickness ¼ 1 mm, number of repetitions ¼ 2. To minimize the effect of the spatially dependent B 1 produced by the surface coil, we tried to position the coil with the same distance from the injection site. A permanent marker was used to spot the needle track. In addition, after positioning of the coil, we performed slice-selective calibration of the 90 pulse. The slice with the hypointense signal from the grafted cells was selected based on gradientecho scout images.
SWIFT Imaging
Phantom and in vivo SWIFT imaging were performed with the following parameters: RF excitation was performed with an amplitude and frequency-modulated pulse of the hyperbolic secant (HSn) family (44) with stretching factor (n) of 2, and a time-bandwidth product of 64. The pulse was oversampled by a factor of 16 (31) . Data were collected in 64 gaps in the HSn pulse, and after the pulse, 192 sample points were acquired without gaps. The bandwidths were 100 and 62 kHz; readout times were 2.6 or 4 ms; excitation flip angle varied from 1 to 22
; number of views was 8192; number of averages was 2; FOV was 40 Â 40 Â 40 mm 3 in vivo and 60 Â 60 Â 60 mm 3 in vitro; total scan time was approximately 3 min. A magnetization preparation scheme with chemically selective pulses (30-ms duration) was applied in mice studies to suppress the fat signal. After acquiring a full set of frequency-encoded projections, 3D images were reconstructed with CMRRpack v0.45b SWIFT software (45) using correlation and a 3D gridding algorithm with 0.156 3 -and 0.234 3 -mm 3 isotropic voxel size for the in vivo and in vitro experiments, respectively (46) .
Quantification of Imaging Data
Quantifications of NMR signal were performed based on the estimation of longitudinal relaxation time (T 1 ). The T 1 maps were reconstructed in MATLAB using a variable flip angle method (36) . T 1 color maps were created using ImageJ software (NIH image). A conversion of gray scale into color images was performed with a "spectrum" color map. Figure 1a shows the percentage of viable MSCs after overnight incubation of cells with different concentrations of iron oxide particles. The cell viability was not reduced (Fig. 1a, black bars) . At the same time, no substantial internalization of iron into the cells was detected by mass spectroscopy. A maximum of approximately 6 pg of iron per cell was found after the MSC incubation with 200 mg/mL of iron oxide in the media ( Table 1 ). The incubation of the MSCs with the Feraheme-low-PLL mixture led to more than three-fold increase in iron accumulation. A maximum of approximately 22 pg of iron per cell was detected after overnight incubation with 200 mg/mL of iron oxide in the media (Table 1) . No reduction in cell viability was detected in MSCs incubated with Feraheme-low-PLL mixture at iron concentrations up to 1000 mg/mL (Fig. 1a,  gray bars) . Incubation of MSCs with Feraheme-high-PLL mixture led to more than 20% reduction in cell viability at the iron concentration higher than 100 mg/mL of iron (Fig.  1a, empty bars) . Because the Feraheme-low-PLL mixture did not produce toxic effects and led to higher iron accumulation in MSCs, we used this mixture in future experiments.
RESULTS
Toxicity Analysis of the Iron Oxide Particles
To confirm that the Feraheme-low-PLL mixture did not cause any long-term toxicity of MSCs, we tested the cell viability of iron oxide-labeled cells at 1, 5, 10, and 21 days after labeling. The cell viability remained the same as the control/unlabeled cells with all Ferahemelow-PLL concentrations tested (Fig. 1b) . To further investigate the effect of the Feraheme-low-PLL mixture on MSCs, we performed osteoblast differentiation of labeled MSCs. Optical analysis indicated that there was no difference in MSC differentiation into osteoblasts between the iron oxide-labeled MSCs and unlabeled MSCs. However, an insignificant decrease in the number of differentiated cells was observed with increasing iron oxide concentrations (Fig. 1c) . Based on these data, we decided to use the labeling concentrations of iron oxide particles less than 400 mg/mL. From these in vitro experiments, we concluded that concentrations of Feraheme-low-PLL mixture in incubation media lower than 400 mg/mL had no adverse effect on the MSCs' viability, proliferation, and osteoblast differentiation. Generation of Hyperintense Signal from Iron-Labeled Cells
Hyperintense Signal from Oxide Solutions in a Phantom
In the next experiments, we assessed the capacity of the SWIFT sequence to generate a hyperintense signal from iron-labeled cells. First, we performed imaging of the phantom with the iron oxide solutions. Figure 2 depicts SWIFT MR images of a phantom consisting of eight tubes with different concentrations (0-30 mg/mL) of iron oxide particles acquired at 2, 10, and 20 excitation flip angles (Figs. 2a-2c, respectively) . The low flip angle acquisition provided a weak but detectable signal from pure water, whereas an increase of the flip angle led to a reduction of pure water signal and an increase in the signal intensity from the iron-containing solutions. Figure 2d depicts a graph of MRI signal intensity as a function of the excitation flip angle. Maximum signal intensity for a lower iron concentration (50 mg/m) was detected at a low flip angle ($10 ), whereas a higher iron concentration (200 mg/m) required a higher excitation flip angle ($15 ) to reach a maximum. We used this property in our in vivo experiments to optimize the contrast between tissue and iron-labeled MSCs.
To determine the optimal concentration of iron oxide particles for the generation of the hyperintense signal, we measured the SWIFT MRI signal intensity from different concentrations of iron oxide at different excitation flip angles (Fig. 2e) . The MRI signal increases initially, reaches a maximum, and decreases again with increasing iron concentration. There are two important issues related to this experiment: First, the version of SWIFT sequence and acquisition parameters we used in these experiments did not allow us to recover MRI signal from the vial with very high concentrations of iron (30000 mg/ mL). Second, a blurring of the images of the vials with high concentrations (!300 mg/mL) of iron oxide particles was observed. To avoid blurry images from iron-labeled cells, we decided to conduct our future labeling and imaging experiments with iron concentrations less than 300 mg/mL.
Hyperintense Signal from Iron Oxide Solution in Muscle Tissue
To confirm that hyperintense signal intensity can be reproduced in vivo, a solution of iron oxide particles was injected into muscle tissue of a mouse. Figure 3a shows the gradient-echo image of mouse hindlimb after the administration of 50 mL of 50-mg/mL Feraheme solution. The signal void in the injection area was detected. Figure 3b shows the SWIFT MR images of the same animal. The distinct hyperintense signal was observed at the injection site. The maximum contrast between muscle tissue and the iron solution was detected at approximately 10 excitation flip angle (Fig. 3b) . 
Quantification of SWIFT Signal from Iron Oxide Solutions
Positive signal intensity allowed the quantification of iron oxide in the solution. We implemented the variable flip angle method to produce an R 1 map (R 1 $1/T 1 ) of the phantom and correlated the concentration of iron oxide with the longitudinal relaxivity of Feraheme (36) . Figure  4a shows a SWIFT image of the phantom with low concentrations (less than 300 mg/mL at 2 excitation flip angle) of the iron oxide particles. No blurring of images was detected at these iron oxide concentrations. Figure  4b shows the R 1 map of the phantom, and Figure 4c shows the T 1 relaxivity versus iron oxide concentrations. A linear relationship between iron oxide concentration and R 1 was detected in this experiment (Fig. 4c) .
To ensure that the iron quantification could be performed in vivo, we performed R 1 mapping of mouse hindlimb after injecting 50 mL of 50-mg/mL iron oxide solution in the muscle (Figs. 4d and 4e) . The R 1 value of the injected solution in the muscle tissue was compared with the R 1 value of the calibration phantom (Fig. 4c) .
The R 1 values from the region of interest of injected area had a range of 3.8 to 0.6 (1/s) with a mean value of 1.8 6 0.8 (1/s), whereas the R 1 value of the same concentration of iron oxide solution in the phantom was 2.2 6 0.1 (1/s).
To make sure that the linear relationship between R 1 relaxivity and the iron oxide concentration was maintained after internalization of the iron particles into the MSCs, we performed R 1 mapping of the phantom with 1 Â 10 6 , 2 Â 10 6 , and 3 Â 10 6 iron-labeled cells, labeled with 18 pg per cell (labeling concentration of iron oxide ¼ 50 mg/mL). A linear dependence of R 1 relaxivity on the concentration of iron-labeled cells was observed (Fig. 4f) .
Hyperintense Signal from Iron-Labeled MSCs in Vivo
To confirm that iron-labeled MSCs can be imaged with SWIFT pulse sequence in vivo, and how long after injection these cells can be detected using MRI, we grafted 18 Â 10 6 MSCs labeled with approximately 22 pg per cell (labeling solution of iron oxide ¼ 200 mg/mL) into muscle tissue of mouse hindlimb. The SWIFT MR imaging was performed at approximately 1 h, 3 days, 10 days, and 19 days after injection. Figure 5a shows the in vivo SWIFT MR image of a mouse hindlimb before the injection of iron-labeled MSCs. Imaging of the animal approximately 1 h after the administration of labeled MSCs revealed a very distinct hyperintense signal from the injection site at high excitation flip angles (Fig. 5b) . Maximum contrast (the difference between signal intensity from labeled cells and tissue) was detected at approximately 15 excitation flip angle. R 1 mapping of tissue revealed the longitudinal relaxivity R 1 ¼ 2.7 6 0.5 1/s in the area of the injection. At day 3 after the implantation of the labeled MSCs (Fig. 5c ), the hyperintense signal had higher intensity with the maximum contrast at approximately 16 excitation flip angle and R 1 ¼ 3.3 6 0.9 1/s. At days 10 and 19, the intensity of the hyperintense signal from grafted cells gradually declined (Figs. 5d and 5e) . A maximum contrast was observed at flip angle of 10 (R 1 ¼ 2.3 6 0.5 1/s) and 6 (R 1 ¼ 1.9 6 0.7 1/s) for days 10 and 19, respectively. The R 1 values and corresponding iron concentrations from the injection sites at the different time points are shown in Figure 5f .
DISCUSSION
Although T Ã 2 -weighted MRI has been used successfully for the imaging of grafted cells (47) , it produces a hypointense signal from iron-labeled cells, which makes their quantification and detection challenging in areas with low signal intensity, such as bone. In this study, we demonstrated that the SWIFT pulse sequence can produce a very distinct hyperintense signal from ironlabeled MSCs. We were able to follow and quantify the hyperintense signal from grafted cells for up to 19 days after administration of 18 Â protocols are useful for cell-tracking studies, as grafted cells can be readily observed and quantified.
Imaging of iron-labeled cells with SWIFT pulse sequence was reported earlier by Zhou et al. (37) . They demonstrated SWIFT imaging of a phantom with ironlabeled cells with distinct hyperintense signals; however, when the same cells were injected into mouse myocardium, a hypointense signal was observed with a marginal enhancement on magnitude images. The motivation for the current study was to improve this method and to generate a clear hyperintense signal from grafted cell in the tissue. In the following, we offer a few tips for the selection of labeling and acquisition parameters to produce a hyperintense signal from iron-labeled donor cells, and to quantify the imaging data.
Hyperintense Signal from Iron Oxide Particles
A distinct feature of the SWIFT sequence is that the excitation and acquisition of NMR signal have minimal separation: The acquisition delay (echo time) is approximately a few microseconds. Extremely short acquisition delay almost eliminates the T 2 dependence of the MRI signal and makes SWIFT images primarily T 1 -weighted. With the SWIFT sequence, the intensity of the hyperintense signal from fast relaxing spins can be adjusted by varying the excitation flip angle. We demonstrated this capability in our phantom experiment with different iron oxide particle solutions (Fig. 2) . A suppression of pure water (long T 1 ) signal and an increase in the signal intensity from the iron-containing solutions (short T 1 ) after the increase of the excitation flip angle were clearly observed in our study (Fig. 2d) . The maximum signal intensities for the solutions with different T 1 were detected at different flip angles (Fig. 2d) . These flip angles are in agreement with the T 1 relaxation times for the solutions and correlate with the Ernst equation (data not shown). An optimization of the excitation flip angle in SWIFT sequence is a powerful approach to produce contrast between a tissue and grafted iron-labeled cells. The high intracellular concentration of the iron oxide accelerates the relaxation rate of nearby water protons, and a larger area of signal void appears on the MR images. In our previous experiments, we attempted to maximize the intracellular iron uptake and were limited only by the ability of cells to uptake iron oxide and the toxic effect of the contrast media (41) . Generation of the hyperintense signal from iron-labeled cells with the SWIFT acquisition protocol applies an additional limitation. When the concentration of iron oxide becomes too high, the signal intensity starts to decline (Fig. 2e) . The reduction of the signal intensity at high iron concentration is caused by the extreme acceleration of the T 2 relaxation rate. When T 2 becomes comparable or shorter than the acquisition dwell time ($1/bandwidth), the signal intensity begins to decrease (25) (Fig. 2e) . In addition to the reduction of the signal intensity, extremely short T 2 also leads to the broadening of the point spread function (27) and blurring of the image. In our phantom experiments, we observed image blurring at iron concentrations higher than 300 mg/mL, whereas the vial with 30000-mg/mL solution was not visible at all (Fig. 2a-2c) . Acquisition with higher bandwidth reduces blurring and allowed the detection of a signal with shorter T 2 (36) . To ensure that our in vivo images would not have blurring artifacts, we decided to use the labeling concentration of iron oxide lower than 300 mg/mL and acquired images with 100-kHz bandwidth.
Effect of Iron Oxide Particles on MSCs
Another factor that we considered when choosing the labeling concentration of iron oxide was the toxic effect of the particles on MSCs. Pre-incubation of MSCs with Ferahem-low-PLL mixture resulted in the internalization of up to approximately 22 pg of iron per cells with no reduction in proliferation, differentiation, or viability of MSCs. A similar level of labeling of MSCs was reported earlier after pre-incubation of iron oxide with PLL (39) or protamine sulfate (48) . A 10-fold increase in the concentration of the transfection agent led to substantial reduction of cell viability. Twenty percent of the cell death was observed after overnight incubation of MSCs with 100 mg/mL of iron oxide and 7.5 mg/mL of PLL mixture. To minimize the toxic effect of the contrast agent and transfection agent on donor cells, we used the labeling protocol with the low concentration of PLL.
Quantification of SWIFT Imaging Data
We used linear dependence of the iron oxide concentration and R 1 relaxivity to quantify the amount of iron in the tissue after administration of the iron oxide solution in muscle tissue (Fig. 4c) . Reasonable agreement with the calibration curve was detected (Figs. 4c and 4e) . A wide distribution of R 1 values in the tissue was detected: 3.8 to 0.6 1/s. Close examination of the injected area revealed that the central part of the injection area has pixels with higher relaxivity than pixels on the periphery.
There are two main factors that affect the longitudinal relaxation in the presence of paramagnetic centers: (i) the surface area of the particle-liquid interface; and (ii) the diffusion capability of protons (49) . Water protons in the heterogeneous tissue must overcome several obstacles (eg, cells membranes, floating macromolecules, different viscosity) to interact with iron oxide particles, whereas in the homogenous aqueous solution, iron oxide particles are readily accessible for the interaction with protons. This difference in accessibility of protons (lower diffusion) may change the relaxivity of iron oxide in the tissue. Aggregation of the iron oxide particles might be another reason for R 1 heterogeneity in the tissue (smaller surface area). Additional information about the quantification of iron oxide in the tissue can be found in other publications from our group (50) .
We also investigated the R 1 relaxivity of iron oxide after internalization of this particle into MSCs. In the phantom with different amounts of iron-labeled cells, a linear dependence was detected (Fig. 4f) . The linear dependence of R 1 relaxivity on the number of the labeled cells indicates that the variable flip angle method can be used for the quantitation of labeled cells' dilution. However, further experiments are needed to determine the R 1 relaxivity of iron-labeled cells in the tissue, and to determine that this relaxivity is time-independent.
Longitudinal Detection of Iron-Labeled Cells
The goal of our final experiment was to confirm that the proposed protocols allow the detection of iron-labeled MSCs. We were also interested in determining how long after injection the iron-labeled cells can be identified and to quantify with SWIFT imaging. A distinct hyperintense signal from iron-labeled MSCs was observed for 19 days after implantation of 18 Â 10 6 cells (Figs. 5a-5e ). Similar results were reported previously (41) , but with the hypointense signal from grafted cells. For the quantification of the iron oxide in the muscle tissue after administration of labeled MSCs, we used the calibration obtained in the iron solution experiment (Fig. 4c) . The lower R 1 value (R 1 ¼ 2.7 6 0.5 1/s) 1 h after injection is probably caused by the partial volume averaging effect: long T 1 signal from PBS (used to resuspend the labeled cells), partially masked the short T 1 signal from ironlabeled cells. After 3 days, the PBS most likely diffused out from the injection area and the remaining cells revealed higher hyperintense signal (R 1 ¼ 3.3 6 0.9 1/s). The recalculation of T 1 relaxivity into the iron concentration revealed the presence of approximately 62 mg/mL of iron in the injected area at 1 h after injection and 80 mg/ mL of iron at day 3. The gradual decrease of R 1 values in the injected area was observed from day 3 to day 19 after injection, which corresponds to the further reduction of the iron concentration from 52 to 43 mg/mL of iron. The decrease of iron concentration in the injected area can be attributed to the death of grafted cells and uptake/removal of the iron oxide particles by immune cells. A dilution of the intracellular iron caused by migration of the labeled cells from the injection site can also contribute to this decrease. The delineation of all possible reasons for the degradation of MRI signal from injected cells over time required more systematic biological experiments and is beyond the scope of this study.
The recent publication by Wang et al. (51) provided a scheme to suppress signals from fat and tissues with long T 2 . Two additional RF pulses were suggested to accomplish this goal, and images with an improved contrast between the host tissue and the injected iron oxide particles were presented. In our work, we suggested a different strategy. Acquisition of images with higher flip angles (flip > 10 0 ) provided a better contrast/visibility of the grafted solution, whereas low flip angle images (flip < 10 0 ) provided a better anatomical representation of the tissue (Fig. 3) . This strategy can reduce the total acquisition time, simplify the sequence, and eliminate any potential problems associated with ghosting as a result of additional RF excitation.
In addition, one of the limitations of conventional T Ã 2 -weighted imaging for the detection of iron-labeled cells is the inability to distinguish donor cells and hemosiderin. We did not have a chance to investigate in detail the appearance of a hemosiderin on SWIFT images. However, our preliminary experiments have shown that hemorrhages appear dark on SWIFT images at a flip angle range from 5 to 25 . This would be an advantage of the proposed method, as it will allow to differentiate between grafted cells (hyperintense signal) and hemosiderin (hypointense signal). However, more systematic studies are needed to determine the optimal imaging parameters.
There are several weaknesses in our experimental design. For the quantification of the amount of iron in the tissue, we made several assumptions: (i) The R 1 relaxivity of the iron-labeled cells in the tissue is not significantly different compared with the aqueous solution (Fig. 4c) ; and (ii) relaxivity or iron-labeled cells remained constant at different days after injection. These assumptions have to be tested and corrections may be applied.
The goal of our labeling protocol was to create a unique R 1 signature of the donor cells, which will clearly differentiate them from host tissue on R 1 map. Our experiment with the bolus injection of iron-labeled MSCs showed that it is possible for the muscle tissue. However, more optimization will be needed to image grafted cells injected into different organs. In addition, we used the simplest model of cell implantation, which did not describe complicated processes of extensive migration and differentiation of grafted cells into different types of tissues. Therefore, the time period when the labeled cells can be detected could vary significantly in more advance animal model of cell therapy.
The main goal of this study was to demonstrate the feasibility of hypointense signal intensity generation and quantification of the iron-labeled MSCs over time. To minimize problems associated with the detection of a small amount of cells, we performed our experiments with a large number of cells (18 Â 10 6 ). Usually, in preclinical studies, lower number of cells (1-10 million) is administered to an animal. We were able to detect very clear hyperintense signal from 5 Â 10 6 cells in the muscle tissue of mice 1 h after injection (data not shown), but did not follow this graft over time. Additional experiments are needed to determine the efficacy of MSC detection and quantification when fewer cells are injected in an animal model with wider migration capabilities of grafted cells.
To increase the signal-to-noise ratio and reduce background signal from the coil itself, we performed our in vivo experiments with a 2-cm surface coil. Inhomogeneity of B 1 field produced by a surface coil can cause errors in the determination of R 1 (36) . To minimize the influence of variation in B 1 field, we tried to position the coil in such a way that the injection area had the same distance to the coil and presumably experienced the same flip angle. We also performed slice-selective calibration of the 90 pulse. This setup is not optimal, and it is more desirable to use volume coils with a homogeneous B 1 field, which we will use in our future experiments. It is also important to mention that most commercial coils have plastic elements that become NMR-visible with SWIFT acquisition. This background signal can cause substantial image distortions.
CONCLUSIONS
In our study, we have shown that the SWIFT pulse sequence allowed the generation of a quantifiable MRI signal from iron-labeled MSCs. Overnight incubation of MSCs with a Feraheme-low-PLL mixture at a concentration of less than 300 mg/mL of iron oxide did not alter long and short-term proliferations, osteoblast differentiation of the cells, or blurring of MR images. Incubation of MSCs with 200 mg/mL of iron oxide led to the accumulation of 22 pg of iron oxide per cell. This intracellular concentration was sufficient to generate a distinct quantifiable hyperintense signal from the graft with the SWIFT pulse sequence. This MRI signal was detected up to 19 days after the injection of 18 Â 10 6 cells into the muscle tissue of mouse hindlimb. The excitation flip angle of the SWIFT sequence can be used for the optimization of the contrast between tissue and iron-labeled cells. This angle depends on the T 1 of iron-labeled cells and tissue. The results obtained in this study are the first steps in developing a noninvasive imaging method to monitor a stem cell therapy of bone disorders.
